APR 1301-01 PKU – Genetic Metabolic Disease
2014-10-14T21:28:27+00:00
- About Us
- APR Products
- Prescription Healthcare Products
- Consumer Healthcare Products
- Therapeutical Areas
- Pipeline
- Our Services
- Media
- Contact
Discover who we are and our partners global network, as well as learn more about our people.
Learn more about our products and how they provide innovative solutions for patiens' unmet needs.
Discover our capabilities in project design services.
Find information such as website news, press releases and event presentations.
Get in touch with us to set up a meeting or propose your cooperation.
APR 1301-01 PKU
GENETIC METABOLIC DISEASE
Inherited metabolic disorders have devastating consequences for patients and their families and effective management is paramount. In certain conditions the cornerstone of management is nutritional and there is an ongoing medical need for appropriately formulated nutritional products and diet management.
APR in collaboration with leading research institutions, is developing APR 1301-01 PKU, an amino-acid based product for use in patients who require protein supplementation as part of their disease management.
